This webinar will discuss the FDA requirements and guidelines for investigating Out-of-trend (OOT) results in the pharmaceutical laboratory. It will also cover FDA-compliant documentation of OOT, failure investigations, root causes, and CAPA.
FDA's guidance on OOS test results requires failure investigations and other steps for Out-of-Specification (OOS) and Out-of-trend (OOT) results. While most companies are familiar with and have procedures for OOS results, this is not the case for OOT situations. The guide states: "Although the subject of this document is OOS results, much of the guidance may be useful for examining results that are out of trend". Managing OOT results also helps to avoid time-consuming OOS results. The industry is unsure how to interpret and implement the FDA guidance.
This session will equip you with the knowledge and comprehensive understanding of FDA requirements for Out-of-Trend Results in pharmaceutical quality control.
FDA's guidance on OOS test results requires failure investigations and other steps for Out-of-Specification (OOS) and Out-of-trend (OOT) results. While most companies are familiar with and have procedures for OOS results, this is not the case for OOT situations. The guide states: "Although the subject of this document is OOS results, much of the guidance may be useful for examining results that are out of trend". Managing OOT results also helps to avoid time-consuming OOS results. The industry is unsure how to interpret and implement the FDA guidance.
This session will equip you with the knowledge and comprehensive understanding of FDA requirements for Out-of-Trend Results in pharmaceutical quality control.
Kelly Thomas Ms. Thomas has over two decades of cGMP hands-on industry experience in both pharmaceutical and medical device manufacturing operations. Her experience covers all Quality Systems; as well as, all areas of validation; including, process/product validation, facilities validation, CSV and 21 CFR Part 11, test method validation, equipment/automated processes and cleaning validation.Utilizing strategic thinking, risk based approaches, and Lean principles, she has demonstrated success in steering and managing complex projects within the pharmaceutical and medical device industries.
Essential Metrics to Measure Accounts Receivable Health
Bad Standard Operating Procedures (SOPs) - Bad Training: Ga…
Three Key Risk Assessments in Your ERM Program - ERM IT and…
HR Metrics & Analytics 2022: Update on Strategic Planning, …
Recent UPDATES to the Rules Stop Payments vs Unauthorized E…
Financial Projections for Determining Long-Term Cash Flow R…
Data Modelling and Analysis with Excel Power Pivot
Impact Assessments For Supplier Change Notices
How to Write Contracts for Procurement Professionals
FDA Regulation of Artificial Intelligence/ Machine Learning
Stay Interviews: A Powerful Engagement and Retention Tool
Harassment, Bullying, Gossip, Confrontational and Disruptiv…
FORM I-9 2022: ICE Announces New Extension Date and Require…
Establishing a Robust Supplier Management Program
Travel and Expense Policy Development and Automation
With Mandatory Paid Leave Gaining Ground, Is It Time To Do …
Project Management for Non-Project Managers
Implementing an Effective Human Error Reduction Program
How to prepare an effective audit manual for an internal au…
CMO Supplier Quality Agreements: How to Comply with new FDA…
Form 1099 Update 2022: Latest Forms, Rules and Reporting Re…
21 CFR Part 11 - Compliance for Electronic Records and Sign…
Managing Toxic & Other Employees Who have Attitude Issues
The Importance of Packaging and Labeling in Pharmaceutical …
I-9 Audits: Strengthening Your Immigration Compliance Strat…
The Top Ten Excel Functions Everyone Should Know